An Immunogenicity and Safety Study of Tetanus, Diphtheria and Acellular Pertussis Vaccine Booster (Q61980650)

From Wikidata
Jump to navigation Jump to search
clinical trial
edit
Language Label Description Also known as
English
An Immunogenicity and Safety Study of Tetanus, Diphtheria and Acellular Pertussis Vaccine Booster
clinical trial

    Statements

    Tdap Booster (English)
    0 references
    An Immunogenicity and Safety Study of Combined Adsorbed Tetanus, Low Dose Diphtheria and Acellular Pertussis Vaccine (Td5ap and Td1aP) Given as a School-leaving Booster to 14-15-year-old Children Primed With a Five Component Acellular Pertussis Vaccine at 3, 5 and 12 Months of Age, and a Booster Dose at 5½ Years of Age (English)
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    April 2009
    0 references
    October 2009
    0 references
    400
    0 references
    14 year
    0 references
    15 year
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit